has been cited by the following article(s):
|
[1]
|
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
|
|
Cancer Cell …,
2022 |
|
|
|
|
[2]
|
Fusion of bacterial flagellin to a dendritic cell-targeting αCD40 antibody construct coupled with viral or leukemia-specific antigens enhances dendritic cell maturation …
|
|
Frontiers in …,
2020 |
|
|
|
|
[3]
|
Lohner
|
|
Hanel, G., Maiser,., Hauke, M …,
2020 |
|
|
|
|
[4]
|
Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model
|
|
2020 |
|
|
|
|
[5]
|
Fusion of bacterial flagellin to a dendritic cell-targeting αCD40 antibody construct coupled with viral or leukemia-specific antigens enhances dendritic cell …
|
|
2020 |
|
|
|
|
[6]
|
Novel multifunctional antibody constructs combining antigen and adjuvant delivery to dendritic cells as a therapeutic vaccine
|
|
2020 |
|
|
|
|
[7]
|
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
|
|
Molecular Therapy,
2018 |
|
|
|
|
[8]
|
Bacterial flagellin-a potent immunomodulatory agent.
|
|
Experimental & molecular medicine,
2017 |
|
|
|
|
[9]
|
Bacterial flagellin—a potent immunomodulatory agent
|
|
Experimental & Molecular Medicine,
2017 |
|
|
|
|
[10]
|
Enhancement of anti-tumor effect of particulate vaccine delivery system by'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
|
|
Nanomedicine,
2015 |
|
|
|
|
[11]
|
Formulation, characterization and validation of CpG functionalized PLGA bacteriomimetic nanoparticles for breast cancer immunotherapy
|
|
2015 |
|
|
|
|
[12]
|
Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic'CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
|
|
2015 |
|
|
|
|
[13]
|
Dendritic Cells Primed with Protein–Protein Fusion Adjuvant
|
|
Cancer Vaccines. Springer,
2014 |
|
|
|
|
[1]
|
Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model
Human Vaccines & Immunotherapeutics,
2021
DOI:10.1080/21645515.2020.1763693
|
|
|
|
|
[2]
|
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells
Frontiers in Immunology,
2020
DOI:10.3389/fimmu.2020.602802
|
|
|
|
|
[3]
|
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Molecular Therapy,
2018
DOI:10.1016/j.ymthe.2017.10.020
|
|
|
|
|
[4]
|
Bacterial flagellin—a potent immunomodulatory agent
Experimental & Molecular Medicine,
2017
DOI:10.1038/emm.2017.172
|
|
|
|
|
[5]
|
Enhancement of anti-tumor effect of particulate vaccine delivery system by ‘bacteriomimetic’ CpG functionalization of poly-lactic-co-glycolic acid nanoparticles
Nanomedicine,
2015
DOI:10.2217/nnm.14.144
|
|
|
|
|
[6]
|
Cancer Vaccines
Methods in Molecular Biology,
2014
DOI:10.1007/978-1-4939-0345-0_7
|
|
|
|